Royalty Pharma (RPRX.US) will release its Earnings Reports before the market opens on May 08.

$Royalty Pharma(RPRX.US)$ will release its Earnings Reports before the market opens on May 8, and investors should pay attention. How were the previous results? $Royalty Pharma(RPRX.US)$ reported revenue of $0.594 billion and a net income of $0.334 billion in Q4 2024, with an EPS of $0.353. In Q1 2024, revenue was $0.568 billion, net income was -$-4.273 million, and EPS was $0.01. The accounting standards used for the above data are US_GAAP. Futubull reminds: 1. Listed Hong Kong and US stocks

Moomoo News21:00 ET

Fund Update: CULLEN/FROST BANKERS, INC. Added 247,903 Shares of $RPRX to Their Portfolio

Quiver Quantitative12:06 ET

Press Release: PureTech Announces Annual Results -37-

Dow JonesApr 30 02:00 ET

FDA Approves Second Drug Product Manufacturing Facility For ADSTILADRIN; Ferring Secures Final $200M Payment From Royalty Pharma

BenzingaApr 24 08:35 ET

Royalty Pharma PLC (RPRX) Surged Following an Acquisition Announcement

Yahoo FinanceApr 24 08:16 ET

Royalty Pharma To Go Ex-Dividend On May 16th, 2025 With 0.22 USD Dividend Per Share

Moomoo NewsApr 22 19:35 ET